NCT03262818View on ClinicalTrials.gov

Transvaginal Ultrasound and Photoacoustic Imaging of the Ovary

PHASE1CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

February 1, 2017

Primary Completion Date

November 19, 2018

Study Completion Date

November 20, 2018

Conditions
Oophorectomy
Interventions
DEVICE

Transvaginal ultrasound

-Will be performed by US technologists at Washington University School of Medicine and read by Dr. Cary Siegel or Dr. Kathryn Robinson

DEVICE

Ultrasound/Photoacoustic imaging

-The light illumination for the photoacoustic imaging system is provided by a wavelength-tunable Ti:Sapphire laser (LOTIS TII), optically pumped by an Nd:YAG laser (LOTIS TII) at 532 nm wavelength.

Trial Locations (1)

63110

Washington University School of Medicine, St Louis

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Washington University School of Medicine

OTHER

NCT03262818 - Transvaginal Ultrasound and Photoacoustic Imaging of the Ovary | Biotech Hunter | Biotech Hunter